9.8.2 Interferie S.A. and Interferie Medical SPA Sp. z o.o.
in PLN millions, unless otherwise stated
On 21 February 2022, KGHM Fundusz Inwestycyjny Zamknięty Aktywów Niepublicznych (hereafter: the Fund), with 100% of its Investment Certificates held by KGHM Polska Miedź S.A., sold all of its directly held shares in the company Interferie Medical SPA Sp. z o.o. with its head office in Legnica, that is 41 309 shares representing 67.37% of the share capital and the same percent of votes at the shareholders’ meeting to Polski Holding Hotelowy sp. z o.o. The Fund’s indirect subsidiary – INTERFERIE S.A. – held the remaining 32.63% of the share capital of the company Interferie Medical SPA Sp. z o.o.
On 28 February 2022, as a result of the settlement of the call for the sale of shares of INTERFERIE S.A. (hereafter “the company”), announced by Polski Holding Hotelowy sp. z o.o., the portfolio companies of the Fund: Fundusz Hotele 01 Sp. z o.o. S.K.A. and Fundusz Hotele 01 Sp. z o.o sold all of their shares in the company, that is in total 10 152 625 shares, representing 69.71% of the share capital and the same percent of votes at the general meeting.
Due to the above, neither the Parent Entity nor any entities of the Group has any shares in the companies: INTERFERIE S.A. and Interferie Medical SPA Sp. z o.o.
The total sale price for the shares of both companies (payable in cash) amounted to PLN 167 million and exceeded the value of net assets attributable to the Group by PLN 37 million. The result on the sale (income) was recognised in the item „Other operating income”.
The activities of the companies Interferie S.A. and Interferie Medical SPA Spółka z o.o. were presented in the segment – Other segments.
The financial data of the above-mentioned companies were presented together with continued operations in the consolidated statement of profit or loss, the consolidated statement of cash flows and explanatory notes to these statements because they do not represent a major line of business and they are not a part of a larger plan to dispose of a major line of business (IFRS 5.32 a and b).
| As at 28 February 2022 | As at 31 December 2021 | |
| ASSETS | ||
| Other property, plant and equipment | 244 | 244 |
| Other property, plant and equipment and intangible assets | 244 | 244 |
| Non-current assets | 244 | 244 |
| Inventories | 1 | 1 |
| Trade receivables | 2 | 2 |
| Tax assets | 1 | 1 |
| Other non-financial assets | 3 | – |
| Cash and cash equivalents | 15 | 15 |
| Current assets | 22 | 19 |
| TOTAL ASSETS IN DISPOSAL GROUP | 266 | 263 |
| LIABILITIES | ||
| Borrowings, leases and debt securities | 65 | 65 |
| Employee benefits liabilities | 1 | 1 |
| Other liabilities | 6 | 3 |
| Non-current liabilities | 72 | 69 |
| Borrowings, leases and debt securities | 12 | 16 |
| Trade payables | 6 | 7 |
| Employee benefits liabilities | 1 | 4 |
| Tax liabilities | 4 | 1 |
| Other liabilities | 5 | 4 |
| Current liabilities | 28 | 32 |
| TOTAL LIABILITIES IN DISPOSAL GROUP | 100 | 101 |
| from 1 January 2022 to 28 February 2022 |
from 1 January 2021 to 31 December 2021 |
|
| Revenues | 14 | 71 |
| Costs | (15) | (68) |
| Profit/(loss) on operating activities | (1) | 3 |
| Finance costs | – | (2) |
| Profit/(loss) before income tax | (1) | 1 |
| Income tax expense | – | – |
| PROFIT/(LOSS) FOR THE PERIOD | (1) | 1 |
| from 1 January 2022 to 28 February 2022 |
from 1 January 2021 to 31 December 2021 |
|
| Net cash generated from operating activities | 1 | 4 |
| Net cash used in investing activities | (1) | (11) |
| Net cash generated from financing activities | – | 17 |
| TOTAL NET CASH FLOW | – | 10 |